SecBot SecBot
SC 13G/A ·Filed Oct 21, 2026

HEPA

Hepion Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5d 1h ago SEC0001493152-26-047920
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion of this 13G to a 13D, which would signal a shift to activist intent. The 7.2% stake and warrant position give Rickel meaningful influence, but the passive filing suggests no near-term control activity.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d
HEPA ▲ +3.70% at T+1d
NEUTRAL call +3.70% · α vs SPY +4.23% · entry $0.1350 → $0.1400
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
+3.70%
call +3.70% · α +4.23%
$0.1400
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Kenneth Rickel, a director of Hepion Pharmaceuticals, filed an amended Schedule 13G disclosing beneficial ownership of 7,250,000 shares (7.2% of outstanding common stock as of August 31, 2026), including 2,000,000 shares issuable upon exercise of warrants. The filing is a routine passive ownership update with no change in stake direction indicated.

Key Financial Metrics

Stake
7.2%
Investor
Kenneth Rickel

Key Facts

  • Kenneth Rickel reported beneficial ownership of 7,250,000 shares of Hepion Pharmaceuticals common stock.
  • The stake represents 7.2% of shares outstanding based on a denominator of 98,220,317 shares as of August 31, 2026.
  • Includes 2,000,000 shares issuable upon exercise of warrants.
  • Filed as a passive investor under Rule 13d-1(c), disclaiming any intent to change or influence control.

Financial Impact

No financial impact; passive ownership disclosure with no change in stake direction.

Risk Factors

  • No material risks identified from this filing alone.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001493152-26-047920
Document: 0001493152-26-047920-index.html0001493152-26-047920
Document: 0001493152-26-047920.txt0001493152-26-047920
6 reports for HEPA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HEPA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.1350awaiting T+20—$0.1281 (−5.11%)
Oct 9, 2026
17d ago
8-K
MIXED ★ 6/10
$0.1240awaiting T+20—$0.1281 (+3.31%)
Sep 28, 2026
28d ago
8-K
BEARISH ★ 6/10
$0.0800 $0.1281▼ −60.13%▼ −60.16%$0.1281 (−60.12%)
Aug 12, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$0.0700 $0.0550▼ −21.43%▼ −19.68%$0.1281 (+83.00%)
Apr 21, 2026
26w ago
Insider Cluster
MIXED ★ 5/10
$0.0700 $0.0750▲ +7.14%▲ +1.67%$0.1281 (+83.00%)
Apr 21, 2026
26w ago
Insider Cluster
MIXED ★ 6/10
$0.0620 $0.0750▲ +20.97%▲ +16.01%$0.1281 (+106.61%)
Showing 6 of 6

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 21, 2026